Page 185 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.2. Trends in prostate cancer incidence rates (per 100,000 unless otherwise stated)

Author Database Groups 1980-84 1985-89 1990-94 1995-99 2000-04 2005- Statistical Notes
Year 10 analysis
PMID
Patient
characteristics –
Age
17
Hankey SEER 50-59 NA 3.8 (2.7, 32.7 (12.5, 1.9 (-4.2, Annual Additional
1999 4.9) 56.4) 8.5) percentage information
10379964 60-69 2.3 (1.5, (1973-89) (1989-92) (1992-95) changes is
3.1) 8.4 (6.1, 24.2 (17.8, -9.0 (-11.2, calculated presented
70-79 (1973- 10.8) 30.9) -6.7) from joinpoint in Figure 2
84) (1984-89) (1989-92) (1992-95) regression of the
≥80 NA 3.3 (2.5, 16.5 (10.7, -16.9 (- (95% CI). paper.
Annual 4.1) 22.7) 21.1, -12.6)
percentage NA (1973-88) (1988-92) (1992-95)
change of the 0.8 (-0.2, 6.4 (3.6, -22.1 (-
age-standardized 1.9) 9.3) 27.1, -16.8)
(1970 US (1973-85) (1985-92) (1992-95)
standard)
incidence rates
79
Merrill SEER 65-69 +3.25 (2.63,
1999 70-74 (1973) (1986) 3.87)
10522656 75-79 +2.83 (2.43,
≥80 3.23)
≥65 +2.12 (1.78,
Annual change in 2.46)
age-adjusted +1.32 (0.90,
incidence rates 1.75)
(1970 world +2.27 (1.99,
standard) 2.56)
[Annual
percentage
change and
corresponding
95% CI]

C-10